🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans

Larry Biegelsen

Stock Analyst at Wells Fargo

(4.32)
# 1,397
Out of 5,152 analysts
1379
Total ratings
54.9%
Success rate
5.2%
Average return

Stocks Rated by Larry Biegelsen

Zimmer Biomet Holdings
Nov 17, 2026
Upgraded: Buy
Price Target: $113 → $123
Current: $103.32
Upside: +19.05%
Edwards Lifesciences
Nov 16, 2026
Rated: Buy
Price Target: $113 → $121
Current: $105.23
Upside: +14.99%
Anteris Technologies Global
Nov 13, 2026
Rated: Buy
Price Target: $16
Current: $5.21
Upside: +207.10%
HeartFlow
Nov 13, 2026
Rated: Buy
Price Target: $39 → $70
Current: $45.89
Upside: +52.54%
NeuroPace
Nov 13, 2026
Downgraded: Hold
Price Target: $19 → $9
Current: $8.22
Upside: +9.49%
Alcon Inc.
Nov 11, 2026
Rated: Buy
Price Target: CHF 71.84
Current: CHF 62.32
Upside: +15.27%
NovoCure
Nov 10, 2026
Reiterated: Hold
Price Target: $15
Current: $10.73
Upside: +39.79%
Becton, Dickinson and Company
Nov 6, 2026
Upgraded: Buy
Price Target: $157 → $242
Current: $216.08
Upside: +12.00%
Enovis
Nov 6, 2026
Rated: Buy
Price Target: $33 → $37
Current: $27.10
Upside: +36.53%
Globus Medical
Nov 6, 2026
Rated: Buy
Price Target: $99 → $100
Current: $70.53
Upside: +41.78%
Rated: Hold
Price Target: $70 → $95
Current: $86.48
Upside: +9.85%
Reiterated: Hold
Price Target: $144 → $172
Current: $139.98
Upside: +22.87%
Reiterated: Buy
Price Target: $27 → $25
Current: $17.05
Upside: +46.63%
Rated: Hold
Price Target: $9 → $6
Current: $5.01
Upside: +19.76%
Reiterated: Hold
Price Target: $56 → $69
Current: $58.11
Upside: +18.74%
Rated: Buy
Price Target: $14 → $12
Current: $7.06
Upside: +69.97%
Reiterated: Hold
Price Target: $19 → $25
Current: $26.16
Upside: -4.43%
Rated: Hold
Price Target: $46 → $49
Current: $48.01
Upside: +2.06%
Reiterated: Buy
Price Target: $28
Current: $14.33
Upside: +95.39%
Reiterated: Buy
Price Target: $112 → $120
Current: $104.48
Upside: +14.85%
Rated: Hold
Price Target: $15 → $13
Current: $13.86
Upside: -6.20%
Rated: Buy
Price Target: $487 → $486
Current: $420.95
Upside: +15.45%
Reiterated: Buy
Price Target: $282 → $287
Current: $272.70
Upside: +5.24%
Reiterated: Buy
Price Target: $28
Current: $28.29
Upside: -1.03%
Reiterated: Buy
Price Target: $90
Current: $82.52
Upside: +9.06%
Reiterated: Buy
Price Target: $48
Current: $56.95
Upside: -15.72%
Rated: Hold
Price Target: $50 → $48
Current: $43.64
Upside: +9.99%
Reiterated: Hold
Price Target: $18
Current: $20.95
Upside: -14.08%
Rated: Buy
Price Target: $348
Current: $318.15
Upside: +9.38%
Reiterated: Hold
Price Target: $66 → $61
Current: $60.75
Upside: +0.41%
Reiterated: Buy
Price Target: $104
Current: $100.72
Upside: +3.26%
Reiterated: Buy
Price Target: $26
Current: $16.99
Upside: +53.03%
Rated: Buy
Price Target: $85
Current: $83.66
Upside: +1.60%
Reiterated: Hold
Price Target: $374
Current: $320.60
Upside: +16.66%
Rated: Hold
Price Target: $74 → $83
Current: $85.93
Upside: -3.41%
Rated: Buy
Price Target: $138 → $178
Current: $233.08
Upside: -23.63%
Reiterated: Hold
Price Target: $116 → $138
Current: $165.85
Upside: -16.79%
Reiterated: Hold
Price Target: $280 → $270
Current: $242.61
Upside: +11.29%
Reiterated: Hold
Price Target: $3
Current: $2.69
Upside: n/a
Rated: Hold
Price Target: n/a
Current: $0.5449
Upside: n/a
Reiterated: Buy
Price Target: $26 → $20
Current: $102.00
Upside: n/a
Downgraded: Hold
Price Target: $15 → $1.4
Current: $6.74
Upside: n/a
Upgraded: Buy
Price Target: n/a
Current: $155.21
Upside: n/a